0QAH.LSE Merck & Company Inc

Healthcare Commercial Services & Supplies London Exchange
148.44 USD
Close of Nov 3, 2026
83.46 157.92
Market cap
USD 373B
P/E
21.4x
P/B
8.81x
ROE
-
Dividend yield
2.19%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 0QAH.LSE undervalued?

Graham number
Price148.44
Graham value51.23
Premium189.7%

0QAH.LSE trades 189.7% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Merck & Company Inc fundamental analysis

No fundamental analysis for Merck & Company Inc yet.

Merck & Company Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Merck & Company Inc

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccine…

Full company profile